Bifidobacteria support optimal infant vaccine responses/Experiment 3/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2025/04/15

Curator: ShadeAkinremi

Revision editor(s): ShadeAkinremi, Victoria

Source: Extented figure 6(j, k, l) And Supplementary Table 11a&b

Description: Differentially abundant microbial species in stool samples collected from Neo-ABX infants at week 6 compared to No-ABX infants. Only taxa detected in >5% of samples are considered for differential abundance analysis.

Abundance in Group 1: decreased abundance in Neonatal Antibotic (Neo-ABX) group [Week-6]

NCBI	Quality Control	Links
Bifidobacterium
Bifidobacterium adolescentis
Bifidobacterium angulatum
Bifidobacterium bifidum
Bifidobacterium breve
Bifidobacterium pseudocatenulatum
Collinsella aerofaciens
Collinsella sp002232035Collinsella sp002232035
Collinsella sp900540095Collinsella sp900540095
Bifidobacterium sp002742445Bifidobacterium sp002742445

Revision editor(s): ShadeAkinremi, Victoria